Stock Events

Stock Events

Syensqo. 

$9.48
175
+$0.00+0% Wednesday 19:01

Statistics

Day High
9.55
Day Low
9.55
52W High
9.55
52W Low
9.39
Volume
400
Avg. Volume
82
Mkt Cap
985.17M
P/E Ratio
-
Dividend Yield
1.99%
Dividend
0.19

Upcoming

Dividends

1.99%Dividend Yield
Jun 26
$0.19
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

5NovExpected
Q4 2023
Q1 2024
Q2 2024
Q3 2024
1.25
1.81
2.37
2.94
Expected EPS
1.83759325398
Actual EPS
N/A

Financials

1.64%Profit Margin
Profitable
2021
2022
2023
2024
2025
2026
1.8BRevenue
29.51MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SYNSY. It's not an investment recommendation.
Solvay SA
59
SOLB.BR
Microsoft
35
MSFT
Ageas SA/NV
34
AGS.BR
Aedifica SA
33
AED.BR

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap5.58B
CRISPR Therapeutics is a competitor because it also focuses on developing gene-based therapies, similar to Syensqo's approach in genetic medicine.
Editas Medicine
EDIT
Mkt Cap485.31M
Editas Medicine operates in the gene editing space, making it a direct competitor to Syensqo in the field of genomic medicine.
Intellia Therapeutics
NTLA
Mkt Cap1.8B
Intellia Therapeutics is involved in CRISPR/Cas9 gene editing, competing with Syensqo in the development of genetic therapies.
Beam Therapeutics
BEAM
Mkt Cap3.03B
Beam Therapeutics competes with Syensqo through its advancements in base editing, a novel form of gene editing technology.
Alnylam Pharmaceuticals
ALNY
Mkt Cap31.73B
Alnylam Pharmaceuticals specializes in RNAi (RNA interference) therapeutics, competing with Syensqo in the broader genetic medicine space.
Ionis Pharmaceuticals
IONS
Mkt Cap10.15B
Ionis Pharmaceuticals, known for its work in RNA-targeted drug discovery and development, competes with Syensqo in the genetic therapy market.
Voyager Therapeutics
VYGR
Mkt Cap218.13M
Voyager Therapeutics focuses on the development of gene therapies for severe neurological diseases, positioning it as a competitor to Syensqo.

About

SPECIALTY HOLDCO BELGIUM
Show more...
CEO
Mr. Christopher Roger Davis B.Com., C.A.
Country
Belgium
ISIN
US87124M1099
WKN
000A3EK24

Listings

F
DE
2NF0.F
STU
DE
2NF.STU
OTC Link
US
SYNSY
F
DE
2NF.F

0 Comments

Share your thoughts

FAQ

What is Syensqo. stock price today?▼
The current price of SYNSY is $9.48 USD — it has increased by +0% in the past 24 hours. Watch Syensqo. stock price performance more closely on the chart.
What is Syensqo. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Syensqo. stocks are traded under the ticker SYNSY.
What is Syensqo. market cap?▼
Today Syensqo. has the market capitalization of 985.17M
What is Syensqo. revenue for the last year?▼
Syensqo. revenue for the last year amounts to 1.8B USD.
What is Syensqo. net income for the last year?▼
SYNSY net income for the last year is 29.51M USD.
Does Syensqo. pay dividends?▼
Yes, SYNSY dividends are paid annual. The last dividend per share was 0.19 USD. As of today, Dividend Yield (FWD)% is 1.99%.
In which sector is Syensqo. located?▼
Syensqo. operates in the Other sector.
When did Syensqo. complete a stock split?▼
Syensqo. has not had any recent stock splits.
Where is Syensqo. headquartered?▼
Syensqo. is headquartered in Brussels, Belgium.